Ectodermal Dysplasia
8
3
3
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
25.0%
2 terminated out of 8 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Organization's Unique Protocol ID
FARD (RaDiCo Cohort) (RaDiCo-FARD)
Reproductive Options in Inherited Skin Diseases
Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Ability of a Molecule (Prima) to Restore Physiological Differentiation in Epithelium Expressing Gene p63
Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States
Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia
Clinical Study of Oral Endosseous Titanium Implants in Edentulous Subjects